Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. (2937)
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. (statistical code 2937): exports in August 2026 were JPY 264,650,000 (-43.8% year on year), quantity 37,637 GR, unit price JPY 6,805 per GR. Main destinations: Ireland (55.0%), Italy (35.0%), Republic of Korea (6.7%), Germany (3.0%), Philippines (0.4%). Figures for August 2026 are revised.
Imports in the same month were JPY 1,472,220,000, a trade deficit of JPY 1,207,570,000. (imports: preliminary; exports: revised)
Import statistics for this code
Monthly statistics
| Month | Status | Export value | Quantity | Unit price | Year-on-year |
|---|---|---|---|---|---|
| August 2026 | revised | JPY 264,650,000 | 37,637 | JPY 6,805 | -43.8% |
| July 2026 | revised | JPY 484,491,000 | 18,277 | JPY 26,345 | +56.4% |
| June 2026 | revised | JPY 71,875,000 | 75,966 | JPY 843 | -76.2% |
| May 2026 | revised | JPY 105,961,000 | 21,659 | JPY 4,342 | -58.3% |
| April 2026 | revised | JPY 322,433,000 | 342 | JPY 937,389 | -9.2% |
| March 2026 | revised | JPY 227,391,000 | 5,670 | JPY 39,308 | -73.4% |
| February 2026 | revised | JPY 307,424,000 | 74,285 | JPY 4,112 | +7.7% |
| January 2026 | revised | JPY 192,862,000 | 21,478 | JPY 8,890 | -56.3% |
| December 2025 | revised (second) | JPY 153,073,000 | 35,592 | JPY 4,088 | -54.0% |
| November 2025 | revised (second) | JPY 427,265,000 | 8,466 | JPY 49,758 | +48.8% |
| October 2025 | revised (second) | JPY 286,875,000 | 45,632 | JPY 6,066 | +6.2% |
| September 2025 | revised (second) | JPY 348,885,000 | 36,207 | JPY 9,366 | -47.8% |
| August 2025 | revised (second) | JPY 470,779,000 | 32,862 | JPY 13,792 | +98.8% |
| July 2025 | revised (second) | JPY 309,846,000 | 50,709 | JPY 6,012 | -29.0% |
| June 2025 | revised (second) | JPY 302,445,000 | 27,055 | JPY 11,133 | -34.9% |
| May 2025 | revised (second) | JPY 254,133,000 | 80,731 | JPY 2,947 | -0.2% |
| April 2025 | revised (second) | JPY 354,962,000 | 174,931 | JPY 2,015 | -11.9% |
| March 2025 | revised (second) | JPY 854,899,000 | 42,677 | JPY 20,006 | +222.1% |
| February 2025 | revised (second) | JPY 285,471,000 | 12,219 | JPY 22,469 | -11.4% |
| January 2025 | revised (second) | JPY 441,467,000 | 40,265 | JPY 10,862 | +95.3% |
| December 2024 | final | JPY 332,734,000 | 7,350 | JPY 44,781 | +292.0% |
| November 2024 | final | JPY 287,124,000 | 16,771 | JPY 16,614 | -34.2% |
| October 2024 | final | JPY 270,052,000 | 13,790 | JPY 18,441 | +246.3% |
| September 2024 | final | JPY 668,963,000 | 27,595 | JPY 24,089 | +25.9% |
Subcategories
- Somatotropin, its derivatives and structural analogues
- Insulin and its salts
- Other
- Cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone)
- Halogenated derivatives of corticosteroidal hormones
- Oestrogens and progestogens
- Other
- Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues
- Other
API and MCP
No API key required. An optional API key gives you a dedicated quota of 1,000 requests per day that is not affected by congestion (free at https://data.washutrading.com/register/).
Example API request for this item: https://data.washutrading.com/api/v1/series?code=2937&flow=export